n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine has been researched along with triiodothyronine in 1 studies
| Studies (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Trials (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Recent Studies (post-2010) (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Studies (triiodothyronine) | Trials (triiodothyronine) | Recent Studies (post-2010) (triiodothyronine) |
|---|---|---|---|---|---|
| 78 | 0 | 12 | 26,247 | 861 | 3,473 |
| Protein | Taxonomy | n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine (IC50) | triiodothyronine (IC50) |
|---|---|---|---|
| Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0006 | |
| Thyroid hormone receptor beta | Homo sapiens (human) | 0.0006 | |
| Proliferating cell nuclear antigen | Homo sapiens (human) | 3.6 | |
| Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | 0.0031 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.4109 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gadina, M; Tao-Cheng, JH; Wu, YN; Youle, RJ | 1 |
1 other study(ies) available for n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and triiodothyronine
| Article | Year |
|---|---|
Retinoic acid disrupts the Golgi apparatus and increases the cytosolic routing of specific protein toxins.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Antibodies, Monoclonal; Biological Transport; Brefeldin A; Cell Line; Ceramides; Cholecalciferol; Cyclopentanes; Cytosol; Fluorescent Dyes; Gene Expression Regulation; Golgi Apparatus; Humans; Immunotoxins; Mannosidases; Rats; Receptors, Retinoic Acid; Ricin; Tretinoin; Triiodothyronine; Tumor Cells, Cultured | 1994 |